Investor Relations authority, working with a range of public and private biopharmaceutical companies across a spectrum of market caps and developmental stages. Expertise in company financings and public listings, regulatory approvals, and commercial launch. Crafts compelling company narratives to help clients achieve fair market value.
Known as
The resident economist, disseminating economic data, CPI trends, and other financial news—and as a horology nerd.